The year in cardiothoracic and vascular anesthesia: selected highlights from 2016

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023001%3A_____%2F17%3A00075849" target="_blank" >RIV/00023001:_____/17:00075849 - isvavai.cz</a>

Výsledek na webu

<a href="http://www.sciencedirect.com/science/article/pii/S1053077016304980?via%3Dihub" target="_blank" >http://www.sciencedirect.com/science/article/pii/S1053077016304980?via%3Dihub</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1053/j.jvca.2016.10.009" target="_blank" >10.1053/j.jvca.2016.10.009</a>

Jazyk výsledku

angličtina

Název v původním jazyce

The year in cardiothoracic and vascular anesthesia: selected highlights from 2016

Popis výsledku v původním jazyce

THIS SPECIAL ARTICLE is the 9th in an annual series for the Journal of Cardiothoracic and Vascular Anesthesia.1 The authors thank the editor-in-chief, Dr. Kaplan, and the editorial board for the opportunity to continue this series, namely the research highlights of the year that pertain to the specialty of cardiothoracic and vascular anesthesia. The major themes selected for 2016 are outlined in this introduction, and each highlight is reviewed in detail in the main body of the article. The literature highlights in the specialty for 2016 begin with the rapidly evolving developments in minimally invasive cardiac procedures, including transcatheter aortic valve replacement (TAVR). Given this rapid progress, it is likely that the indications for this disruptive technology will expand beyond high- and intermediate-risk patients to include low-risk patients with severe aortic stenosis (AS). The second major theme in the specialty for 2016 was the set of major trials that recently explored the role of surgical therapy in ischemic heart disease with respect to interventions such as surgical ventricular restoration, coronary artery bypass grafting (CABG), and mitral valve repair. The third major theme for the specialty in 2016 was the progress in platelet blockade and coronary stents that prompted recent guidelines for dual-antiplatelet therapy (DAPT) in ischemic heart disease. The fourth major theme for the specialty in 2016 was the role of steroids in cardiac surgery with cardiopulmonary bypass (CPB), given the publication of recent landmark randomized trials. The themes selected for this 9th special article are only a sample of the advances in the specialty during 2016. These highlights likely will further improve important perioperative outcomes for patients with cardiovascular disease.

Název v anglickém jazyce

The year in cardiothoracic and vascular anesthesia: selected highlights from 2016

Popis výsledku anglicky

THIS SPECIAL ARTICLE is the 9th in an annual series for the Journal of Cardiothoracic and Vascular Anesthesia.1 The authors thank the editor-in-chief, Dr. Kaplan, and the editorial board for the opportunity to continue this series, namely the research highlights of the year that pertain to the specialty of cardiothoracic and vascular anesthesia. The major themes selected for 2016 are outlined in this introduction, and each highlight is reviewed in detail in the main body of the article. The literature highlights in the specialty for 2016 begin with the rapidly evolving developments in minimally invasive cardiac procedures, including transcatheter aortic valve replacement (TAVR). Given this rapid progress, it is likely that the indications for this disruptive technology will expand beyond high- and intermediate-risk patients to include low-risk patients with severe aortic stenosis (AS). The second major theme in the specialty for 2016 was the set of major trials that recently explored the role of surgical therapy in ischemic heart disease with respect to interventions such as surgical ventricular restoration, coronary artery bypass grafting (CABG), and mitral valve repair. The third major theme for the specialty in 2016 was the progress in platelet blockade and coronary stents that prompted recent guidelines for dual-antiplatelet therapy (DAPT) in ischemic heart disease. The fourth major theme for the specialty in 2016 was the role of steroids in cardiac surgery with cardiopulmonary bypass (CPB), given the publication of recent landmark randomized trials. The themes selected for this 9th special article are only a sample of the advances in the specialty during 2016. These highlights likely will further improve important perioperative outcomes for patients with cardiovascular disease.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30201 - Cardiac and Cardiovascular systems

Projekt

—

Návaznosti

N - Vyzkumna aktivita podporovana z neverejnych zdroju

Rok uplatnění

2017

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Journal of cardiothoracic and vascular anesthesia

ISSN

1053-0770

e-ISSN

—

Svazek periodika

31

Číslo periodika v rámci svazku

1

Stát vydavatele periodika

US - Spojené státy americké

Počet stran výsledku

13

Strana od-do

1-13

Kód UT WoS článku

000398248900001

EID výsledku v databázi Scopus

—